These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 3057835)

  • 1. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology and cellular biology of Hodgkin's disease.
    Slivnick DJ; Nawrocki JF; Fisher RI
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):205-20. PubMed ID: 2663823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].
    Rubio MT; Ghesquières H; Blay JY; Salles G
    Bull Cancer; 2001 Nov; 88(11):1081-90. PubMed ID: 11741802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological aspects of Hodgkin's disease].
    Bianchini E
    Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hodgkin and Sternberg-Reed cells--cell origin, cell marker, cell function].
    Plat M; Kunze KD; Frank KH; Fleischer J; Koslowski R; Plat U
    Arch Geschwulstforsch; 1988; 58(6):419-30. PubMed ID: 3066301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte populations of non-scleronodular Hodgkin's disease subtypes in different stages of lymphocyte depletion. An immunophenotypic and quantitative study.
    Valente G; Ferrara P; Stramignoni A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):289-94. PubMed ID: 1970692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD; McClure SP; Banks PM; Gulley ML
    Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reaction of xenogeneic and monoclonal antisera with Reed-Sternberg cells.
    Stuart AE; Jackson E; Morris CS
    J Pathol; 1982 Jun; 137(2):129-38. PubMed ID: 6979620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.